SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2327There's also another home-run possibility if this works in metabolic syndromBiomaven-6/8/2009
2326I agree with Peter that the efficacy is pretty darn reasonable, considering it iBiotech Jim-6/8/2009
2325>>Efficacy is only modest Seems pretty decent to me - 0.5% drop on top ofBiomaven-6/8/2009
2324Pre market reaction is favorable, but no more than muted. Not much volume.tom pope-6/8/2009
2323Efficacy is only modest and the PR dances around side effects a bit. I'm nrkrw16/8/2009
2322Confusing, or just plain old doublespeak? <i>Avandia Raises Risk of Hearttom pope-6/7/2009
2321Old news, but takes on significance in light this weekend's news. <i>tom pope-6/7/2009
2320Some Additional Info on Today's Diabetes Study Results and Comparative Perspquantman-6/6/2009
2319Sounds impressive, hope it is.tom pope-6/6/2009
2318Results Presented at the ADA 69th Scientific Sessions Demonstrate that INCB13739Biotech Jim-6/6/2009
2317Thanks from me, too. I had bailed for a modest profit a couple of weeks ago. Ituck-5/28/2009
2316Thanks.ewolf-5/28/2009
2315INCY press release from today suggests both good news and bad news: Bad News: Lquantman15/28/2009
23145/7/09 cc notes very little new info, so a short call today. next few months wisoftware salesperson-5/7/2009
2313Thank you for the sober, accurate summary. Friedman has reason to be subdued butewolf-4/4/2009
23124/1 Citi Bio Day presentation notes 1) 424 MF: re-filed SPA yesterday; expectssoftware salesperson-4/2/2009
2311>>So, are you saying that the mixed shelf actually means that INCY is plantuck-3/8/2009
2310Tuck, So, are you saying that the mixed shelf actually means that INCY is plannquantman-3/7/2009
2309Incyte was weak today when many other biotechs were catching a bid due to the uptuck-3/6/2009
2308Thanks!idos-2/19/2009
2307idos, your question was asked on the 11/1/07 cc: (xvii) % of MPD patients who software salesperson-2/19/2009
2306The overpromotion certainly isn't working with the stock at $3. They have thrkrw-2/19/2009
2305Have INCY estimated the percentage of myeloproliferative disorders patients withidos-2/19/2009
2304Was thinking of the former, which was the world's introduction to the Friedmkeokalani'nui-2/19/2009
2303I thought the issue was just one of having to use surrogate markers like spleen rkrw-2/19/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News